TY  - CONF

T1  - Infrequent zoledronic acid produces sustained increases in bone mineral density (BMD) in patients with cancer treatment induced bone loss (CTIBL)

JO  - CANCER TREATMENT REVIEWS

PY  - 2006/01/01

AU  - Brown JE

AU  - Ellis SP

AU  - Lester JE

AU  - Gutcher S

AU  - Khanna T

AU  - Purohit O

AU  - Coleman RE

ED  - 

VL  - 32

SP  - S19

EP  - S19

Y2  - 2024/12/21

ER  -